Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 12

1.

1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma.

Mackintosh C, Ordóñez JL, García-Domínguez DJ, Sevillano V, Llombart-Bosch A, Szuhai K, Scotlandi K, Alberghini M, Sciot R, Sinnaeve F, Hogendoorn PC, Picci P, Knuutila S, Dirksen U, Debiec-Rychter M, Schaefer KL, de Álava E.

Oncogene. 2012 Mar 8;31(10):1287-98. doi: 10.1038/onc.2011.317. Epub 2011 Aug 8.

PMID:
21822310
2.

Complex rearrangement of chromosomes 19, 21, and 22 in Ewing sarcoma involving a novel reciprocal inversion-insertion mechanism of EWS-ERG fusion gene formation: a case analysis and literature review.

Maire G, Brown CW, Bayani J, Pereira C, Gravel DH, Bell JC, Zielenska M, Squire JA.

Cancer Genet Cytogenet. 2008 Mar;181(2):81-92. doi: 10.1016/j.cancergencyto.2007.11.002. Review.

PMID:
18295659
3.

Ewing tumor: tumor biology and clinical applications.

de Alava E, Pardo J.

Int J Surg Pathol. 2001 Jan;9(1):7-17. Review.

PMID:
11469351
4.

Ewing sarcoma: biology-based therapeutic perspectives.

Potratz J, Jürgens H, Craft A, Dirksen U.

Pediatr Hematol Oncol. 2012 Feb;29(1):12-27. doi: 10.3109/08880018.2011.627582. Review.

PMID:
22304007
5.

Primary vaginal Ewing sarcoma: case report and review of the literature.

Bancalari E, de Álava E, Tardío JC.

Int J Surg Pathol. 2012 Jun;20(3):305-10. doi: 10.1177/1066896911424898. Epub 2011 Oct 17. Review.

PMID:
22007080
6.

Molecular confirmation of Ewing sarcoma.

Dagher R, Pham TA, Sorbara L, Kumar S, Long L, Bernstein D, Mackall C, Raffeld M, Tsokos M, Helman L.

J Pediatr Hematol Oncol. 2001 May;23(4):221-4. Review.

PMID:
11846300
7.

Gain of 1q and loss of 9q21.3-q32 are associated with a less favorable prognosis in papillary thyroid carcinoma.

Kjellman P, Lagercrantz S, Höög A, Wallin G, Larsson C, Zedenius J.

Genes Chromosomes Cancer. 2001 Sep;32(1):43-9. Review.

PMID:
11477660
8.

EWS-ETS oncoproteins: the linchpins of Ewing tumors.

Janknecht R.

Gene. 2005 Dec 19;363:1-14. Epub 2005 Oct 3. Review.

PMID:
16202544
9.

Ewing sarcoma: clinical state-of-the-art.

Potratz J, Dirksen U, Jürgens H, Craft A.

Pediatr Hematol Oncol. 2012 Feb;29(1):1-11. doi: 10.3109/08880018.2011.622034. Review.

PMID:
22295994
10.

Sarcomas gone bad: what to do about recurrent Ewing sarcoma.

Hawkins DS.

Pediatr Blood Cancer. 2011 Oct;57(4):535-6. doi: 10.1002/pbc.23126. Epub 2011 Jun 16. Review. No abstract available.

PMID:
21681926
11.

Innovative therapies in Ewing Sarcoma.

Amaral AT, Ordóñez JL, Otero-Motta AP, García-Domínguez DJ, Sevillano MV, de Álava E.

Adv Anat Pathol. 2014 Jan;21(1):44-62. doi: 10.1097/PAP.0000000000000003. Review.

PMID:
24316910
12.

Molecular characterization of bone tumors and implications for treatment and prognosis.

Monument MJ, Jones KB.

J Natl Compr Canc Netw. 2014 Feb;12(2):214-20. Review.

PMID:
24586083
Items per page

Supplemental Content

Write to the Help Desk